Your browser doesn't support javascript.
loading
ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria.
Castellani, C; De Boeck, K; De Wachter, E; Sermet-Gaudelus, I; Simmonds, N J; Southern, K W.
Affiliation
  • Castellani C; IRCCS Istituto Giannina Gaslini, Cystic Fibrosis Center, Via Gerolamo Gaslini, Genoa 16147, Italy. Electronic address: carlocastellani@gaslini.org.
  • De Boeck K; Department of Pediatrics, University of Leuven, Leuven, Belgium.
  • De Wachter E; Cystic Fibrosis Center, Pediatric Pulmonology department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
  • Sermet-Gaudelus I; INSERM U1151, Institut Necker Enfants Malades, Université de Paris, Centre de référence Maladies Rares, Mucoviscidose et maladies apparentées. Hôpital Necker Enfants malades, Paris, France.
  • Simmonds NJ; Adult Cystic Fibrosis Centre, Royal Brompton Hospital and Imperial College, London, United Kingdom.
  • Southern KW; Department of Women's and Children's Health, University of Liverpool, Alder Hey Children's Hospital, Liverpool, United Kingdom.
J Cyst Fibros ; 21(6): 908-921, 2022 11.
Article in En | MEDLINE | ID: mdl-36220763
ABSTRACT
This paper is the first in a series providing updated guidance on the definition, evaluation and management of people with a Cystic Fibrosis Transmembrane conductance Regulator (CFTR)-Related Disorder (CFTR-RD). The need for this update relates to more precise characterisation of CFTR gene variants and improved assessment of CFTR protein dysfunction. The exercise is co-ordinated by the European CF Society Standards of Care Committee and Diagnostic Network Working Group and involves stakeholder engagement. This first paper was produced by a core group using an extensive literature review and papers graded for their quality. Subsequent wider stakeholder agreement was achieved. The definition of a CFTR-RD remains "a clinical condition with evidence of CFTR protein dysfunction that does not fulfil the diagnostic criteria for CF". Clearer guidance on CFTR dysfunction and relevant CFTR variants will be provided. Thresholds for clinical presentations are presented and the paradigm that pathobiological processes may be evident in more than one organ is agreed. In this paper we reflect on the early patient journey, highlighting that CF specialists as well as other relevant specialists should be involved in the care of people with a CFTR-RD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis Transmembrane Conductance Regulator / Cystic Fibrosis Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: J Cyst Fibros Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis Transmembrane Conductance Regulator / Cystic Fibrosis Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: J Cyst Fibros Year: 2022 Document type: Article